Genotype/phenotype correlations in multiple endocrine neoplasia type 2
Endocrine-Related Cancer · 15.10.2024 · 31 (12)
DOI: 10.1530/erc-24-0139 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, erschienen am 15.10.2024. Verfasst von Frederic Castinetti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille University, INSERM, MMG, Department of Endocrinology, La Conception Hospital, Assistance Publique Hopitaux de Marseille, Marseille, Fra…. Hauptthemen laut MEDLINE: Multiple Endocrine Neoplasia Type 2a, Proto-Oncogene Proteins c-ret, Genetic Association Studies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Graphical abstract Abstract Multiple endocrine neoplasia type 2 (MEN 2) is a rare hereditary endocrine tumor syndrome caused by mutations in the rearranged during transfection (RET) gene. MEN 2 is divided into two main entities, MEN 2A and MEN 2B, both of which present with medullary thyroid cancer (MTC) in approximately 100% of cases and pheochromocytoma in 50% of cases. Specific RET mutations are associated with a risk of early onset of MTC, from 1 year of age (highest risk) to 5 years of age (high risk). This risk defines the optimal timing for thyroidectomy, ideally at an age when the disease has not spread. This is the most important genotype-phenotype correlation observed in MEN 2. Specific RET mutations also define the penetrance of pheochromocytoma. However, despite the presence of these highest/high-risk variants, some patients unexpectedly present with non-aggressive MTC or never present with pheochromocytoma, suggesting that factors other than the major RET variant may modify the natural history and genotype-phenotype correlations. Improving our understanding of the genotype-phenotype correlations would allow individualizing the management and follow-up of patients with MEN 2. The aim of this brief review is to discuss the main genotype-phenotype correlations in MEN 2 and the potential factors that might influence these correlations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aix Marseille University, INSERM, MMG, Department of Endocrinology, La Conception Hospital, Assistance Publique Hopitaux de Marseille, Marseille, France.
- Department of Medical Genetics and Genomics, Medical Specialties Institute, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Frederic Castinetti, Charis Eng
Zitieren
APA
Castinetti, F., & Eng, C. (2024). Genotype/phenotype correlations in multiple endocrine neoplasia type 2. Endocrine-Related Cancer, 31(12). https://doi.org/10.1530/erc-24-0139
Vancouver
Castinetti F, Eng C. Genotype/phenotype correlations in multiple endocrine neoplasia type 2. Endocrine-Related Cancer. 2024;31(12). doi:10.1530/erc-24-0139
BibTeX
@article{Castinetti2024,
author = {Castinetti, Frederic and Eng, Charis},
title = {Genotype/phenotype correlations in multiple endocrine neoplasia type 2},
journal = {Endocrine-Related Cancer},
year = {2024},
volume = {31},
number = {12},
doi = {10.1530/erc-24-0139}
}
EUVIMED